Delivery Order SPE2DB20D3505-SPE2DB24FT4C8
- Not listed
- This federal contract award, valued at $1,555.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract is for the delivery of Icosapent Ethyl 1 gram capsules, a pharmaceutical product used for cardiovascular health. This...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,229.78 for the pharmaceutical product Icosapent Ethyl 1 gram capsules. The contract was awarded by the Defense Logistics Agency (DLA) on January 20, 2023, with a completion date of January 23, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 18, 2024. The $20,757.04 firm fixed-price delivery order is for the supply of Icosapent Ethyl 1 gram capsules. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $14,087.56, is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. The contract has a period of performance through September 6, 2023 and is structured as a firm fixed-price delivery order. The award was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger...
- This federal contract award is for the delivery of Icosapent Ethyl 0.5 GM capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,227.39 and a completion date of June 2, 2023. It is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award, valued at $2,664.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Icosapent Ethyl 1 gram capsules (120 count). The award has a completion date of January 31, 2023 and is structured as a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for Award...
- This federal contract award, valued at $1,232.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- This federal contract award is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $1,782.14. The contract is a Firm Fixed Price Delivery Order with a completion date of September 5, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- The federal contract award SPE2DB20D3505|SPE2DB23FT6H4 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,412.31 fixed-price delivery order is for the supply of 4559771141 - Icosapent Ethyl 1 Gram Capsule 120s, with a completion date of January 31, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This delivery order, valued at $2,322.47, was awarded to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count units) with an ultimate completion date of October 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The Defense Logistics Agency, which serves the Department of Defense's medical supply chain requirements, is the funding federal agency, and the place of...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT4C8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,526.51 firm-fixed-price delivery order is for the supply of Icosapent Ethyl 1 gram capsules. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order, along with the broader IDC, demonstrates Amerisourcebergen's role as a critical supplier of essential medications and medical commodities to the U.S. Department of Defense and other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/30/23 |